Sort
78,016 grants matching “breast cancer”
Systemic Glucocorticoid Signaling Induced by Breast Cancer Cell Derived Extracellular Vesicles
$534,083Shizhen Emily Wang · University Of California, San Diego · R01 · FY2025 · CA
Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label
$534,032Michael Rod Zalutsky · Duke University · P01 · FY2016 · CA
Functional, cellular, and molecular imaging and therapy monitoring using ultrasou
$534,022Stanislav Y Emelianov · University Of Texas At Austin · R01 · FY2013 · CA
Epigenomics of Neurocognitive Function in Breast Cancer
$534,005Yvette P Conley · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Development of an apoptosis biosensor for monitoring of breast cancer
$533,998Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · EB
Role of the Follicle-Depleted Ovary in the Pathogenesis of Chronic Diseases
$533,987Jay R Kaplan · Wake Forest University Health Sciences · R01 · FY2008 · AG
MBSR Symptom Cluster Trial for Breast Cancer Survivors
$533,981Cecile A Lengacher · University Of South Florida · R01 · FY2012 · CA
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
$533,949Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2022 · CA
Hypnosis for Hot Flashes: A Randomized Clinical Trial
$533,901Gary R Elkins · Baylor University · U01 · FY2008 · AT
EPIGENETIC HETEROGENEITY AND TARGETS IN TRIPLE-NEGATIVE BREAST CANCER
$533,807Dana-Farber Cancer Institute, Inc. · · FY2018 · Department of the Army
IRS2 and mitotic regulation in breast cancer
$533,806Leslie M Shaw · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
IRS2 and mitotic regulation in breast cancer
$533,806Leslie M Shaw · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
$533,791Robert J Gray · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Translation of In-Clinic Gains to Gains in Daily Life
$533,722Catherine E Lang · Washington University · R37 · FY2023 · HD
The Reproductive Window in Young Adult Cancer Survivors
$533,722Hui-Chun Irene Su · University Of California, San Diego · R01 · FY2017 · HD
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$533,720Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2019 · CA
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
$533,688Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2021 · CA
Homogenized, engineered extracellular vesicles for intracranial targeting
$533,627Randy Carney · University Of California At Davis · R01 · FY2023 · EB
Convergent AI for Precise Breast Cancer Risk Assessment
$533,624Stephen Tc Wong · Methodist Hospital Research Institute · R01 · FY2020 · CA
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$533,603Melissa J Suter · Massachusetts General Hospital · R01 · FY2015 · CA
Macrophage phenotype polarization in clinical neoplasia
$533,583Jan Matt Van De Rijn · Stanford University · R01 · FY2019 · CA
INTEGRATED ISOLATION &MOLECULAR ANALYSIS OF TUMOR CELLS
$533,576University Of Texas Md Anderson Can Ctr · R33 · FY2003 · CA
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity
$533,556Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)
$533,546University Of Pennsylvania · R24 · FY2000 · CA
Pathology Image Informatics Platform for visualization, analysis and management
$533,529Anant Madabhushi · Case Western Reserve University · U24 · FY2019 · CA